SciELO - Scientific Electronic Library Online

 
vol.23 número4Síndromes clínicos en la infección aguda y crónica de la COVID-19 en población nativa y residente de altura durante la primera y segunda ola índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Horizonte Médico (Lima)

versão impressa ISSN 1727-558X

Resumo

DIAZ SANTIAGO, Hasalia et al. Factors associated with adherence to drug therapy among patients with diabetes without hypertension. Horiz. Med. [online]. 2023, vol.23, n.4, e2383.  Epub 18-Dez-2023. ISSN 1727-558X.  http://dx.doi.org/10.24265/horizmed.2023.v23n4.01.

Objective:

To identify the factors associated with adherence to drug therapy among patients with type 2 diabetes mellitus without hypertension.

Materials and methods:

A cross-sectional, analytical study conducted with patients with type 2 diabetes mellitus without hypertension, divided into an adherent group (n = 145) and a non-adherent group (n = 49), determined by the 4-item Morisky Medication Adherence Scale (MMAS-4). The associated factors were sex, cohabitation, schooling, occupation, age in 10-year groups and diabetes progression time grouped in less than 1 year, from 1 to 5 years, from 6 to 10 years and more than 10 years. The statistical analysis plan included the chi-square test.

Results:

The factors associated with adherence to drug therapy were identified as sex (p = 0.045), cohabitation (p = 0.045), age (p = 0.001) and disease progression time (p = 0.001). Schooling was not identified as a factor associated with adherence to drug therapy among patients with type 2 diabetes mellitus (p = 0.289). The older the patient with diabetes, the lower the adherence to drug therapy; the cut-off point was 60 years of age, after which the percentage in the non-adherent group was higher than in the adherent group (p = 0.001). The longer the diabetes progression time, the lower the probability of adherence; in the non-adherent group the percentage of patients with more than 10 years of disease progression was 67.3 % and in the adherent group the percentage was 33.8 % (p = 0.001).

Conclusions:

The factors associated with adherence to drug therapy among patients with type 2 diabetes mellitus without hypertension were identified

Palavras-chave : Medication Adherence; Diabetes Mellitus, Type 2; Essential Hypertension.

        · resumo em Espanhol     · texto em Espanhol | Inglês     · Inglês ( pdf ) | Espanhol ( pdf )